In late 2017 they launched retina-amd.org, a toolkit designed to provide the most up to date scientific information and therapeutic developments in the area of AMD. This information was developed for the members of the patient bodies that make up the coalition to use not only in their local communications and advocacy work but also to ensure those affected or at risk of developing these conditions were up to date on the latest scientific advances, therapy development and rehabilitation services.
In January 2019 Retina Action launched retina-ded.org, a toolkit that provides high quality information to those at risk and affected by Diabetes-related Retinopathy, Diabetes-related Macular Edema and other diabetes-related eye diseases, a group of very complex conditions, to equip advocates with the information they need to educate policy makers on the importance of screening for this degenerative retinal disease.